Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-010504

CEO and Chairman acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pham Quang X · CEO and Chairman

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-10 Grant or award : show line 1 in the form +25,000 $1.94 $48,500 3,300,000 D
Loading xslF345X03/ownership.xml…